RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases-Reference-Cited by-同舟云学术

RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases

Published:2016-03-25 Issue:8 Volume:23 Page:2635-2643
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Brudvik Kristoffer Watten,Mise Yoshihiro,Chung Michael Hsiang,Chun Yun Shin,Kopetz Scott E.,Passot Guillaume,Conrad Claudius,Maru Dipen M.,Aloia Thomas A.,Vauthey Jean-Nicolas

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5187-2.pdf

Reference44 articles.

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18

2. Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125–35.

3. Bradpiece HA, Benjamin IS, Halevy A, Blumgart LH. Major hepatic resection for colorectal liver metastases. Br J Surg. 1987;74:324–6.

4. Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986;73:727–31.

5. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–22.

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of surgical margin on prognosis after hepatectomy for colorectal cancer liver metastases with RAS mutations;Surgical Oncology Insight;2024-09

2. Präzisionsmedizinischer Ansatz für die Metastasenchirurgie viszeraler Tumoren;Die Onkologie;2024-08-21

3. Utility of circulating tumor DNA in secondary liver malignancies: What we know and what is to come;Journal of Surgical Oncology;2024-08-19

4. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?;Surgery;2024-07

5. The Ugly: Metastatic Colon Cancer—Surgical Options;Clinics in Colon and Rectal Surgery;2024-06-18